Metethoheptazine
Group of stereoisomers
- none
- ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
- 509-84-2
N
- 176888
- 154060
Y
- S36J5ZY2TH
- DTXSID30862077
- Interactive image
- O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
InChI
- InChI=1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3Y
- Key:BOSULDNQDJLKKL-UHFFFAOYSA-NY
N
Y (what is this?) (verify)Metethoheptazine[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[2]
Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.
Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.[3] The Canadian Controlled Drugs and Substances Act specifically excludes the phenazepine opioids from control.
References
- ^ GB 843924, "Substituted azacycloheptanes", assigned to American Home Products
- ^ Walkenstein SS, Corradino RA, Wiser R, Gudmundsen CH (February 1965). "Metabolism of the Non-Narcotic Analgesic, WY-5355". Biochemical Pharmacology. 14 (2): 121–8. doi:10.1016/0006-2952(65)90067-5. PMID 14332457.
- ^ "Conversion Factors for Controlled Substances". Diversion Control Division. Drug Enforcement Administration, U.S. Department of Justice. Retrieved 8 October 2018.
- v
- t
- e
Opioid receptor modulators
(MOR)
(DOR)
(KOR)
(NOP)
| Agonists |
|
|---|---|
| Antagonists |
|
- Enkephalinase inhibitors: Amastatin
- BL-2401
- Candoxatril
- D -Phenylalanine
- Dexecadotril (retorphan)
- Ecadotril (sinorphan)
- Kelatorphan
- Racecadotril (acetorphan)
- RB-101
- RB-120
- RB-3007
- Opiorphan
- Selank
- Semax
- Spinorphin
- Thiorphan
- Tynorphin
- Ubenimex (bestatin)
- Propeptides: β-Lipotropin (proendorphin)
- Prodynorphin
- Proenkephalin
- Pronociceptin
- Proopiomelanocortin (POMC)
- Others: Kyotorphin (met-enkephalin releaser/degradation stabilizer)
 | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
